Medical data and technology company HeraMED Limited (ASX:HMD) has signed a binding agreement with FemBridge to develop a scalable maternal health solution. FemBridge and HeraMED have already made good progress on creating a scalable solution that delivers high quality maternal healthcare for preconception through postpartum related health issues and nurturing maternal mental wellbeing.
This agreement follows a Memorandum of Understanding with Fembridge that was announced in December 2023.
FemBridge has developed a comprehensive and empathetic solution dedicated to empowering women throughout their journey from preconception to postpartum. Recognising that women's health extends beyond medical parameters, the approach is both holistic and personalised.
By addressing Social Determinants of Health, providing Access to Technology, implementing Maternal and Fetal home monitoring, delivering personalised virtual coaching, and prioritising mental health screening, support, and treatment, the FemBridge solution ensures that all aspects of a woman’s well-being are considered.
To date FemBridge has been engaged by HeraMED as an outsourced business development function. This binding partnership agreement with FemBridge is a strategically important step for HeraMED's commercialisation strategy in the United States.
HeraMED is moving to a healthcare customer focussed solutions provider. Taking a holistic approach to maternal health allows for platform differentiation and sets HeraMED up as a “one stop shop” for maternal health, aligning it to key behavioural and social drivers of healthcare, and allowing for a more flexible customised solution. This partnership allows HeraMED to expedite this process as FemBridge brings valuable expertise in several key areas for HeraMED.
Under the terms of the binding agreement, FemBridge will provide ten experienced Sales Executives and five Clinical coaches and obstetric registered nurses.
“I’m confident that this agreement represents the start of a successful relationship that has the potential to transform maternal and infant care with our scalable solution, which is needed now more than ever in some parts of USA,” HeraMED Executive Chairman Ron Weinberger said.
